Flow cytometric cell sorting combined with molecular chimerism analysis to detect minimal recurrent leukemia: good news and bad news

Allogeneic BMT offers the possibility of cure for a variety of hematopoietic malignancies, but disease relapse remains a major cause of treatment failure. This report describes two cases in which flow cytometric cell sorting (FACS) and molecular chimerism analysis were combined to increase the sensi...

Full description

Saved in:
Bibliographic Details
Published in:Bone marrow transplantation (Basingstoke) Vol. 19; no. 11; pp. 1157 - 1161
Main Authors: LAMB, L. S, ROBBINS, N. F, ABHYANKAR, S, JOYCE, M, STETLER-STEVENSON, M, HENSLEE-DOWNEY, P. J, GEE, A. P
Format: Journal Article
Language:English
Published: Basingstoke Nature Publishing Group 01-06-1997
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Allogeneic BMT offers the possibility of cure for a variety of hematopoietic malignancies, but disease relapse remains a major cause of treatment failure. This report describes two cases in which flow cytometric cell sorting (FACS) and molecular chimerism analysis were combined to increase the sensitivity of minimal residual disease (MRD) detection. In the first case this approach was used to demonstrate that a suspicious phenotype was not recurrent leukemia, thus preventing the use of potentially toxic therapy. In the second case the recurrence of a leukemia which was undetectable by conventional analysis was confirmed. The potential benefits of combining these MRD detection methods are discussed.
ISSN:0268-3369
1476-5365
DOI:10.1038/sj.bmt.1700800